GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actavia Life Sciences Inc (OTCPK:RASP) » Definitions » Common Stock

Actavia Life Sciences (Actavia Life Sciences) Common Stock : $0.77 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Actavia Life Sciences Common Stock?

Actavia Life Sciences's quarterly common stock stayed the same from Jun. 2023 ($0.77 Mil) to Sep. 2023 ($0.77 Mil) and stayed the same from Sep. 2023 ($0.77 Mil) to Dec. 2023 ($0.77 Mil).

Actavia Life Sciences's annual common stock increased from Sep. 2021 ($0.07 Mil) to Sep. 2022 ($0.18 Mil) and increased from Sep. 2022 ($0.18 Mil) to Sep. 2023 ($0.77 Mil).


Actavia Life Sciences Common Stock Historical Data

The historical data trend for Actavia Life Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actavia Life Sciences Common Stock Chart

Actavia Life Sciences Annual Data
Trend Jun14 Jun15 Jun16 Mar17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.07 0.07 0.18 0.77

Actavia Life Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.77 0.77 0.77 0.77

Actavia Life Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Actavia Life Sciences (Actavia Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2525, New York, NY, USA, 10170
Rasna Therapeutics Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Actavia Life Sciences (Actavia Life Sciences) Headlines

No Headlines